Hemogenyx Pharmaceuticals Plc (HEMO) Ordinary Shares 1p
- Add to watchlist
- Create an alert
- This stock can be held in a
Share news, reports & tips
-
Hermogenyx shares soar on new partnership with Prevail Partners
18 September 2023 13:00
(Sharecast News) - Shares in biopharma group Hemogenyx surged on Monday after the company received a $0.83m investment from Prevail Partners as it continues to work on its planned clinical trial for...
Company announcements Announcements
-
Total Voting Rights
28 March 2024 07:00
Hemogenyx Pharmaceuticals
-
Placing to Raise US$4.2 million
29 February 2024 07:00
Hemogenyx Pharmaceuticals
-
CBR Intranasal Delivery
14 February 2024 07:00
Hemogenyx Pharmaceuticals
-
FDA Consents to Phase I Trials of HEMO-CAR-T
9 February 2024 07:00
Hemogenyx Pharmaceuticals
-
Approval and Issuance of U.S. Conditioning Patent
2 February 2024 07:00
Hemogenyx Pharmaceuticals
-
Submission of Complete Response to Clinical Hold
16 January 2024 07:00
Hemogenyx Pharmaceuticals
-
HEMO-CAR-T Process Qualification Run Completed
8 January 2024 07:00
Hemogenyx Pharmaceuticals
-
Placing to Raise £534,375
28 November 2023 12:19
Hemogenyx Pharmaceuticals
-
CBR Expanded to Treatment of Cancer
27 November 2023 07:00
Hemogenyx Pharmaceuticals
-
Lentivirus Re-manufacturing Completed
15 November 2023 07:00
Hemogenyx Pharmaceuticals
-
Total Voting Rights
31 October 2023 07:00
Hemogenyx Pharmaceuticals
-
Half-year Report
28 September 2023 12:28
Hemogenyx Pharmaceuticals
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.
© Digital Look Ltd 1998-2024. All rights reserved.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.